Endoscopy Management of Complete Gastric Outlet Obstruction Secondary to Elipse™ Intragastric Balloon

Ciprian, Giulio; Khoury, Jessica; Ramirez, Leandro; Miskovsky, John

doi:10.7759/cureus.17542

Cited by 3 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This raises questions regarding the long-term viability of such treatments without the integration of continuous post-treatment support mechanisms. In addition, several potential complications may occur during the ingestion of the balloon or while the device is located in the stomach, such as gastric outlet obstruction [ 46 ].…”

Section: Discussionmentioning

confidence: 99%

Evaluating Weight Loss Efficacy in Obesity Treatment with Allurion’s Ingestible Gastric Balloon: A Retrospective Study Utilizing the Scale App Health Tracker

Dejeu,

Bradea

et al. 2024

Clinics and Practice

View full text Add to dashboard Cite

Obesity represents a growing public health concern, affecting more than 15% of the global adult population and involving a multi-billion market that comprises nutritional, surgical, psychological, and multidisciplinary interventions. The objective of this retrospective study was to evaluate the short-term efficacy and body weight measurements associated with differing levels of physical activity following the use of Allurion’s ingestible gastric balloon that was designed to increase feelings of fullness and decrease food consumption, being naturally eliminated after approximately 16 weeks. This study involved 571 individuals who qualified for the intervention for being older than 20 years with a body mass index (BMI) of 27 kg/m2 or more. Utilizing the Scale App Health Tracker and Allurion’s smartwatch, this study was able to track vital signs and physical activity in real time. The participants had an average initial BMI of 34.1 kg/m2 and a median age of 41 years. Notable outcomes were observed in both study groups, “Less Active” and “More Active”, which were classified by achieving less or more than a median number of 8000 daily steps. Specifically, body fat percentage saw a reduction from 33.1 ± 9.4 to 28.3 ± 10.2 in the less active group and from 32.2 to 27.5 in the more active group, with both groups achieving statistical significance (p < 0.001). Additionally, there was a significant reduction in average weight, dropping from 98.2 ± 22.8 kg to 84.6 ± 19.3 kg in the less active group and from 97.7 ± 21.0 kg to 82.1 ± 22.9 kg in the more active group (both p < 0.001). Interestingly, those in the more active group also experienced a significant increase in lean mass compared to their less active counterparts (p = 0.045), although no substantial differences in weight loss, BMI reduction, and total body fat decrease were observed between the two groups. This investigation confirms the hypothesis that Allurion’s ingestible gastric balloon significantly reduces weight in the short term and enhances several physical health metrics, demonstrating effectiveness as an autonomous method for challenging weight management, regardless of the level of daily physical activity.

show abstract

Section: Discussionmentioning

confidence: 99%

Evaluating Weight Loss Efficacy in Obesity Treatment with Allurion’s Ingestible Gastric Balloon: A Retrospective Study Utilizing the Scale App Health Tracker

Dejeu,

Bradea

et al. 2024

Clinics and Practice

View full text Add to dashboard Cite

show abstract

“…El 99.9% de los pacientes pueden deglutir la cápsula con el balón. Entre las complicaciones que se han reportado se encuentran el vaciamiento temprano del balón (antes de los 4 meses), obstrucciones intestinales que requieren laparoscopia, hiperinflaciones, esofagitis, pancreatitis, obstrucciones pilóricas y un caso de perforación gástrica [3][4][5] .…”

Section: Discussionunclassified

Balón Allurion: retiro temprano por endoscopia

Romano-Munive¹

2023

END

View full text Add to dashboard Cite

Introducción: El balón gástrico Allurion no requiere endoscopia para su colocación ni para su retiro; sin embargo, hasta el 2.9% de los pacientes no lo toleran, por lo que se requiere su retiro temprano por endoscopia. Objetivo: Conocer las complicaciones asociadas a este balón y la técnica endoscópica para su retiro. Caso clínico: Mujer de 44 años con sobrepeso y estreñimiento crónico a quien se colocó un balón gástrico Allurion, presentando náusea y dolor epigástrico. Recibió tratamiento sin mejoría, por lo que se retiró el balón 2 semanas después. Conclusiones: El balón Allurion requiere endoscopia para resolver la mayor parte de sus complicaciones.

show abstract

The Swallowable Intragastric Balloon Combined with Lifestyle Coaching: Short-Term Results of a Safe and Effective Weight Loss Treatment for People Living with Overweight and Obesity

et al. 2023

View full text Add to dashboard Cite

Background Some patients with overweight or obesity are not eligible for surgery according to international guidelines or do not wish a surgical intervention. For these patients, different treatment options are being explored. In this study, we examined the effectiveness of the swallowable intragastric balloon (IB) combined with lifestyle coaching, in patients living with overweight and obesity. Method A retrospective data study was conducted on patients with a swallowable IB placement between December 2018 and July 2021, combined with a 12-month coaching program. Before balloon placement, patients underwent multidisciplinary screening. The IB was swallowed and filled with fluid once in the stomach and naturally excreted around 16 weeks. Results A total of 336 patients, 71.7% female, were included with a mean age of 45.7 (±11.7) years. Mean baseline weight and BMI were 107.54 (±19.16) kg and 36.1 (±5.02) kg/m2. After 1 year, the mean total weight loss was 11.0% (±8.4). The mean placement duration was 13.1 (±2.82) min, and in 43.7%, a stylet was used to facilitate placement. The most common symptoms were nausea (80.4%) and gastric pain (80.3%). In the majority of patients, complaints were resolved within a week. The early deflation of the balloon occurred in 8 patients (2.4%) of which one showed symptoms suggesting a gastric outlet obstruction. Conclusion Given the low rate of long-term complaints while providing a positive effect on weight loss, we conclude that the swallowable intragastric balloon, combined with lifestyle coaching, is a safe and effective treatment option for patients living with overweight and obesity. Graphical Abstract

show abstract

Endoscopy Management of Complete Gastric Outlet Obstruction Secondary to Elipse™ Intragastric Balloon

Cited by 3 publications

References 7 publications

Evaluating Weight Loss Efficacy in Obesity Treatment with Allurion’s Ingestible Gastric Balloon: A Retrospective Study Utilizing the Scale App Health Tracker

Evaluating Weight Loss Efficacy in Obesity Treatment with Allurion’s Ingestible Gastric Balloon: A Retrospective Study Utilizing the Scale App Health Tracker

Balón Allurion: retiro temprano por endoscopia

The Swallowable Intragastric Balloon Combined with Lifestyle Coaching: Short-Term Results of a Safe and Effective Weight Loss Treatment for People Living with Overweight and Obesity

Contact Info

Product

Resources

About